Replies to post #268358 on Amarin Corp Plc (AMRN)

[ziploc_1]

Captain...This is a good fall back position...if Amarin loses the appeal...Its a good illustration of how a company, which has invested so much time and money and effort in a product, has, in the course of its hard work, back up positions to challenge marauders...Let's hope we never have to dust off this fall back position...It would be better for Amarin and better for America if we didn't.

[sts66]

No Catch-22 on the generic capsule being different - assuming AMRN's patents do protect the capsule ingredients - they just need to have a capsule that provides the same protection against oxidation of the EPA. The inactive ingredients of a generic drug aren't controlled by the FDA, the drug component just needs to work approximately the same way as the brand drug. Every once in a while CVS will change their source of one of my generic drugs - the shape, color, and size of the pill can vary wildly from what I used to get - the generic just contains different amounts of inactive fillers and dyes, amount of drug is still the same.

[NickHous]

Very interesting. Nobody has pondered this point Capt. I like it.

The generics capsule would infringe if its makeup is identical.
On the other hand, if its makeup was different then it the product would not meet the definition of "Generic"

Would be awesome if the capsule was also infused with EPA and we had a patent on that.